Tuberculosis News and Research

Latest Tuberculosis News and Research

PopART project awarded $37 million study grant for HIV prevention in Africa

A team of researchers led by Professor Richard Hayes at the London School of Hygiene and Tropical Medicine has been awarded $37 million to test an innovative combination of strategies to prevent HIV in African countries.

16 Sep 2011

Plans to tackle drug resistant tuberculosis

A plan has been drawn up to tackle the increasing numbers of drug-resistant tuberculosis cases in 53 European countries. Calling the situation alarming, the World Health Organization reports that Eastern Europe has the highest level of infection, while in Western Europe, London has the highest TB rate of any capital city. Russia, Ukraine and Azerbaijan are among the countries with the highest burden of illness. There are an estimated there 81,000 cases of drug-resistant TB a year in Europe. And this is an underestimation say experts.

15 Sep 2011

E.U. announces launch of 126M Euro program to fight AIDS, TB in South Africa

European Development Commissioner Andris Piebalgs announced during a visit to South Africa on Monday that the European Union (E.U.) "will contribute 126 million euros to South Africa's fight against AIDS and tuberculosis (TB)," money that "will be used to improve South Africa's primary health care system, increasing access for patients," Reuters reports.

15 Sep 2011

WHO warns drug-resistant TB spreading in Europe at 'alarming' rate, releases plan to fight disease

Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) "are spreading at an alarming rate in Europe and will kill thousands unless health authorities halt the pandemic, the World Health Organization (WHO) said on Wednesday" during the launch of "a new regional plan to find, diagnose and treat cases of the airborne infectious disease more effectively," Reuters reports.

15 Sep 2011

Without action to curb antibiotic resistance, some diseases may once again become untreatable

In this Atlantic Magazine opinion piece, Megan McArdle, senior editor at the Atlantic, echoes a warning by the FDA issued in 2001 which stated, "Unless antibiotic resistance problems are detected as they emerge, and actions are taken to contain them, the world could be faced with previously treatable diseases that have again become untreatable, as in the days before antibiotics were developed."

15 Sep 2011

Eli Lilly announces $30M commitment to fight NCDs in developing nations

Eli Lilly and Company announced today a $30 million commitment over five years to fight the rising burden of non-communicable diseases in developing nations.

14 Sep 2011

Rwanda to treat HIV-positive people in discordant relationships as soon as they test positive

After a landmark study published in May "showed major reductions in HIV transmission among discordant couples due to early treatment," Rwanda has decided to begin treating people in discordant relationships with antiretroviral therapy as soon as they test HIV-positive "as part of a plan to boost national HIV prevention and treatment efforts," PlusNews reports.

14 Sep 2011

JHUSON nursing research news

In a six-month, randomized controlled study of asthmatic children living with smokers reported in the Archives of Pediatrics and Adolescent Medicine, August 2011, Johns Hopkins University School of Nursing (JHUSON) professor and School of Medicine faculty member Arlene Butz, MSN, CPNP, ScD, and others found that regular use of indoor air cleaners can greatly reduce household air pollution and lower rates of children's daytime asthma symptoms.

12 Sep 2011

Non-communicable disease epidemic a global problem

Later this month the United Nations will convene a high-level meeting on non-communicable diseases. The world's global health news has been so dominated by infectious culprits - HIV/AIDS, malaria, tuberculosis, influenza - that it's easy to forget just how big a toll conditions like diabetes, cancer and heart and lung disease take say experts.

9 Sep 2011

Global Fund facility offering subsidized malaria drugs 'could do more harm than good'

In this article in The American, a journal of the American Enterprise Institute for Public Policy Research, Roger Bate, the Legatum Fellow at the American Enterprise Institute, and Richard Tren, director of Africa Fighting Malaria, write that the Global Fund to Fight AIDS, Tuberculosis, and Malaria "launched a $225 million facility that offers subsidized malaria drugs ...

9 Sep 2011

Human Rights Watch report says foreign aid indirectly supporting forced labor in Vietnam's drug rehabilitation centers

In a report released Wednesday, New York-based Human Rights Watch "accused the United States government, the World Bank and other international donors of indirectly funding forced labor in Vietnam's drug rehabilitation centers," Inter Press Service reports.

9 Sep 2011

TB vaccine candidate shows early potential in mice

Scientists at the Howard Hughes Medical Institute (HHMI), Albert Einstein College of Medicine and Colorado State University report in the September 4 issue of Nature Medicine that "[a] potential vaccine against tuberculosis [TB] has been found to completely eliminate tuberculosis bacteria from infected tissues in some mice," according to a HHMI press release.

8 Sep 2011

Dwindling donor funding in Burundi leads to national shortage of ARVs

"Burundian NGOs say at least 20 people have died" as a result of a "months-long shortage" of antiretroviral drugs (ARVs), although "Ministry of Health officials could not be reached to confirm the number of people affected," PlusNews reports.

7 Sep 2011

African giant pouched rat may be more effective than humans at detecting TB

The Wall Street Journal examines the use of the African giant pouched rat to detect tuberculosis (TB) in lab samples. A study published online in the Pan African Medical Journal last month found the rats are "better than human lab techs at identifying TB bacteria in a dollop of mucus," a finding that "holds promise for diagnosing tuberculosis in sub-Saharan Africa," according to the newspaper.

7 Sep 2011

International public health spending ignores neglected tropical diseases, some experts argue

The Bureau of Investigative Journalism examines what some experts are calling a serious inequity in public health spending, writing that neglected tropical diseases (NTDs) "together kill more people than maternal mortality and have a higher disease burden than malaria or tuberculosis (TB) and nearing that of HIV/AIDS. However, despite the severity of the situation, funding for NTDs is just a fraction of that spent on other diseases."

7 Sep 2011

Genetically modified M. smegmatis vaccine shows promise against TB

An experimental vaccine composed of a genetically modified bacterium closely related to the bacterium that causes tuberculosis (TB) has been found to protect mice against TB infection, according to a study appearing online September 4 in the journal Nature Medicine.

7 Sep 2011

NanoLogix to move R&D operations from Cincinnati to its headquarters in Hubbard

NanoLogix, an innovator in the accelerated detection and identification of microorganisms, announced today it will move its research and development operations from Cincinnati to its headquarters in Hubbard, Ohio.

6 Sep 2011

IKEPLUS immunization completely eliminates TB bacteria from infected tissues

A potential vaccine against tuberculosis has been found to completely eliminate tuberculosis bacteria from infected tissues in some mice. The vaccine was created with a strain of bacteria that, due to the absence of a few genes, are unable to avoid its host's first-line immune response.

5 Sep 2011

Einstein researchers develop tuberculosis vaccine candidate

Researchers at Albert Einstein College of Medicine of Yeshiva University report in the September 4 online edition of Nature Medicine that they have developed a tuberculosis (TB) vaccine candidate that proved both potent and safe in animal studies.

5 Sep 2011

Special journal edition chronicles 3-D structures of important antibacterial, bioterrorist targets

The September issue of the online scientific journal Acta Crystallographica: Structural Biology and Crystallization Communications (Acta Cryst F) will consist entirely of work done at the Seattle Structural Genomics Center for Infectious Disease (SSGCID), a consortium of researchers from Seattle BioMed, Emerald BioStructures, the University of Washington and Pacific Northwest National Laboratory.

2 Sep 2011

Tuberculosis News and Research

Latest Tuberculosis News and Research

PopART project awarded $37 million study grant for HIV prevention in Africa

Plans to tackle drug resistant tuberculosis

E.U. announces launch of 126M Euro program to fight AIDS, TB in South Africa

WHO warns drug-resistant TB spreading in Europe at 'alarming' rate, releases plan to fight disease

Without action to curb antibiotic resistance, some diseases may once again become untreatable

Eli Lilly announces $30M commitment to fight NCDs in developing nations

Rwanda to treat HIV-positive people in discordant relationships as soon as they test positive

JHUSON nursing research news

Non-communicable disease epidemic a global problem

Global Fund facility offering subsidized malaria drugs 'could do more harm than good'

Human Rights Watch report says foreign aid indirectly supporting forced labor in Vietnam's drug rehabilitation centers

TB vaccine candidate shows early potential in mice

Dwindling donor funding in Burundi leads to national shortage of ARVs

African giant pouched rat may be more effective than humans at detecting TB

International public health spending ignores neglected tropical diseases, some experts argue

Genetically modified M. smegmatis vaccine shows promise against TB

NanoLogix to move R&D operations from Cincinnati to its headquarters in Hubbard

IKEPLUS immunization completely eliminates TB bacteria from infected tissues

Einstein researchers develop tuberculosis vaccine candidate

Special journal edition chronicles 3-D structures of important antibacterial, bioterrorist targets

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Tuberculosis News and Research

Latest Tuberculosis News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in